Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Wheeler

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cell Reports|February 17, 2015
HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor GrowthKurosh Ameri, Arman Jahangiri, Anthony M Rajah, et al.
Blood Cancer Discovery|July 14, 2021
Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapyErin W Meermeier, Seth J Welsh, Meaghen E Sharik, et al.
Mabs|December 21, 2019
Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic modelsFeng Wang, Jordan C Tsai, Jonathan H Davis, et al.
Scientific Reports|March 4, 2022
Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo modelJulie A Zorn, Matthew L Wheeler, Ralston M Barnes, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cell Reports|February 17, 2015
HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor GrowthKurosh Ameri, Arman Jahangiri, Anthony M Rajah, et al.
Blood Cancer Discovery|July 14, 2021
Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapyErin W Meermeier, Seth J Welsh, Meaghen E Sharik, et al.
Mabs|December 21, 2019
Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic modelsFeng Wang, Jordan C Tsai, Jonathan H Davis, et al.
Scientific Reports|March 4, 2022
Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo modelJulie A Zorn, Matthew L Wheeler, Ralston M Barnes, et al.
Pageof 2